Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcript
Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.